Page 2 - B Drug Program News Today

The 340B Drug Program requires pharmaceutical manufacturers participating in the Medicaid program to provide covered outpatient drugs at significantly reduced prices to certain health...

The vice president of pharmacy operations at American Oncology Network discusses the 340B Drug Pricing Program and its growth and impact on community oncology.

This Week in Washington: Congress passes Continuing Resolution to keep the government funded until Nov. 17; CMS announces premium increase for Medicare Advantage plans in FY 2024...

At their Monday, Sept. 18 Board Meeting, Estes Park Health’s leadership proposed a series of Phase II Strategic Actions that, if accepted by the Board, would help enable Estes Park Health to accomplish its primary goal to continue to provide high-quality health care services to our Estes Valley residents and visitors for many years to come. Estes Park […]

On Friday, July 7, The Centers for Medicare & Medicaid Services (CMS) published its proposed rule to remedy payment rates the Supreme Court held invalid in a ruling last summer. A key...

Throughout 2022, the 340B Drug Program (340B) and participating hospital systems experienced myriad new developments. From continued disputes with drug manufacturers to a landmark U.S....

As expected, CMS per-day penalties rise drastically in 2021 following agency switch … Supreme Court to hear arguments in case seeking to reverse cuts to 340B Drug Program … Rushed care by nursing home aides tied to behavioral responses from residents with Alzheimer’s

Deputy Secretary and CMS Administrator Picks Would Fill Two Critical Policy Positions   On Thursday, the Senate Finance Committee held a confirmation hearing for two of the most important health policy officials nominated by President Biden, Chiquita Brooks-LaSure (Administrator, Centers for Medicare and Medicaid Services) and Andrea Palm (Deputy Secretary). These are two critical policy positions for Congress to help fill, as the Deputy Secretary is often comparable to the Chief Operating Of...

Monday, January 11, 2021 DHCS”) will be transitioning all Medi-Cal pharmacy benefits from managed care to fee-for-service (“ FFS”).  This new system to administer FFS pharmacy benefits is being called “Medi-Cal Rx” and was developed by DHCS in response California Governor Gavin Newsom’s January 7, 2019 executive order (the “ Order”), which instructed DHCS to transition all Medi-Cal pharmacy benefits to FFS by January 1, 2021.  The rationale behind the Order is to c...